Colour Vision

Colour Vision is a fundamental component of human visual perception, enabling the discrimination of wavelengths that define how we interpret our environment. Disorders of color perception can significantly affect daily functioning, occupational performance, and quality of life. As an important theme within a global Ophthalmology Conference, this topic explores the physiology, genetics, clinical assessment, and management of color perception disorders, including both congenital and acquired conditions. Understanding the mechanisms underlying color discrimination begins with the structure and function of cone photoreceptors in the retina and the neural pathways that transmit chromatic information to the visual cortex.

Congenital color vision deficiencies, most commonly red-green defects, are typically inherited in an X-linked pattern and present early in life. Blue-yellow defects and rare complete achromatopsia represent less common but clinically significant variants. Acquired color vision disturbances may result from optic nerve disease, retinal pathology, systemic conditions, medication toxicity, or neuro-ophthalmic disorders. Differentiating congenital from acquired forms is essential, as acquired defects often signal underlying ocular or neurological disease requiring further investigation.

Diagnostic evaluation has evolved from traditional Ishihara plates to advanced anomaloscopy, computerized color contrast testing, and retinal imaging technologies that correlate structural abnormalities with functional chromatic deficits. Functional MRI studies and electrophysiological assessments are providing deeper insight into cortical color processing. The session also examines occupational screening standards, aviation and maritime requirements, and the psychosocial implications of color vision deficiency in educational and professional settings.

Research into gene therapy for inherited color deficiencies is gaining momentum, with experimental studies demonstrating restoration of cone function in animal models. Advances in optical filters, digital accessibility tools, and assistive applications are also enhancing visual discrimination in affected individuals. Artificial intelligence–based diagnostic tools are improving screening accuracy, particularly in pediatric and large-scale population assessments.

By integrating retinal physiology, genetics, neurobiology, and clinical practice, this scientific discussion promotes a comprehensive understanding of chromatic vision. Collaboration among ophthalmologists, optometrists, neuroscientists, and genetic researchers continues to expand knowledge in this evolving field, fostering innovations that improve detection, counseling, and supportive management strategies for individuals with color vision abnormalities.